TM9SF2 and gastric neoplasm: Mining of the SBCDDB revealed that Tm9sf2 was a common insertion site in 7.2% (121/1674 tumors) of all digestive tumors, which includes liver, pancreas, intestine, and stomach tumors, but was not identified as a driver in hematopoietic tumors (Fig. 1B).